Mucosolvan Market

Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an important role in the body?s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.

Mucosolvan Market contains market size and forecasts of Mucosolvan (Ambroxol) in Global, including the following market information:

Global Mucosolvan (Ambroxol) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mucosolvan (Ambroxol) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mucosolvan (Ambroxol) include Zywie LLC, Sanofi, Hanmi, Adare Pharma, Boehringer Ingelheim, Teijin, Astellas Pharma, Chiesi and Sidus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Mucosolvan (Ambroxol) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mucosolvan (Ambroxol) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mucosolvan (Ambroxol) Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsules

Injections

Solutions

Syrups

Granules

Global Mucosolvan (Ambroxol) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mucosolvan (Ambroxol) Market Segment Percentages, by Application, 2021 (%)

Acute And Chronic Bronchitis

Bronchial Asthma

Bronchiectasis

Emphysema

Tuberculosis (TB)

Pneumoconiosis

Postoperative Medication

Other

Global Mucosolvan (Ambroxol) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mucosolvan (Ambroxol) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mucosolvan (Ambroxol) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mucosolvan (Ambroxol) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Zywie LLC

Sanofi

Hanmi

Adare Pharma

Boehringer Ingelheim

Teijin

Astellas Pharma

Chiesi

Sidus

Takeda

Euderma

Changzhou Siyao Pharmaceuticals

Shandong Fangming Pharmaceutical Group

TIPR Pharmaceutical

Hainan Weikang Pharmaceutical

Sandoz (Novartis)

Sinopharm

Jiangsu Hengrui Pharmaceutical

Yantai Dongcheng Dayang Pharmaceutical

Zhuhai Tongyuan Pharmaceutical

Beijing Taiyang Pharmaceutical

Nanjing Yihua Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Shandong Yuxin Pharmaceutical

CSPC

Shanxi Qianyuan Pharmaceutical Group

Yangtze Pharmaceutical Group

Jiangsu Aosaikang Pharmaceutical

Jiangsu Haosen Pharmaceutical Group

Shenyang Xinma Pharmaceutical